Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.11 - $147.37 $6,061 - $8.12 Million
55,100 Added 13.45%
464,644 $51,000
Q2 2022

Aug 12, 2022

BUY
$0.18 - $0.31 $37,497 - $64,579
208,322 Added 103.53%
409,544 $102,000
Q1 2022

May 13, 2022

BUY
$0.27 - $0.4 $19,845 - $29,400
73,500 Added 57.55%
201,222 $60,000
Q4 2021

Feb 11, 2022

BUY
$0.38 - $0.61 $24,586 - $39,467
64,700 Added 102.66%
127,722 $48,000
Q3 2021

Nov 12, 2021

BUY
$0.58 - $0.69 $36,552 - $43,485
63,022 New
63,022 $40,000
Q1 2021

May 13, 2021

SELL
$0.73 - $1.43 $292,286 - $572,561
-400,393 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$0.52 - $0.81 $110,569 - $172,233
-212,634 Reduced 34.69%
400,393 $279,000
Q3 2020

Nov 13, 2020

BUY
$0.72 - $1.61 $249,912 - $558,831
347,100 Added 130.52%
613,027 $448,000
Q2 2020

Aug 13, 2020

BUY
$0.71 - $1.29 $135,326 - $245,874
190,600 Added 253.03%
265,927 $306,000
Q1 2020

May 14, 2020

SELL
$0.29 - $1.5 $39,796 - $205,845
-137,230 Reduced 64.56%
75,327 $45,000
Q4 2019

Feb 13, 2020

SELL
$0.51 - $0.76 $68,858 - $102,612
-135,017 Reduced 38.85%
212,557 $136,000
Q3 2019

Nov 13, 2019

SELL
$0.45 - $1.73 $29,202 - $112,268
-64,895 Reduced 15.73%
347,574 $212,000
Q2 2019

Aug 12, 2019

BUY
$0.28 - $3.1 $107,140 - $1.19 Million
382,645 Added 1283.01%
412,469 $697,000
Q1 2019

May 14, 2019

BUY
$0.91 - $1.97 $5,369 - $11,623
5,900 Added 24.66%
29,824 $36,000
Q4 2018

Feb 13, 2019

BUY
$0.77 - $1.78 $18,421 - $42,584
23,924 New
23,924 $18,000

Others Institutions Holding NBY

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About NovaBay Pharmaceuticals, Inc.


  • Ticker NBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,988,400
  • Market Cap $43.5M
  • Description
  • NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...
More about NBY
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.